Investigating the limit of detectability of a positron emission mammography device: A phantom study

Nicholas A. Shkumat, Adam Springer, Christopher M. Walker, Eric M. Rohren, Wei Tse Yang, Beatriz Elena Adrada, Elsa Arribas, Selin Carkaci, Hubert Hsing Chuang, Lumarie Santiago, Osama Mawlawi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: A new positron emission mammography (PEM) device (PEM Flex Solo II, Naviscan Inc., San Diego, CA) has recently been introduced and its performance characteristics have been documented. However, no systematic assessment of its limit of detectability has been evaluated. The aim of this work is to investigate the limit of detectability of this new PEM system using a novel, customized breast phantom. Methods: Two sets of F-18 infused gelatin breast phantoms of varying thicknesses (2, 4, 6, and 8 cm) were constructed with and without (blank) small, shell-less contrast objects (2 mm thick disks) of varying diameters (3-14.5 mm) volumes: 0.15-3.3 cc and activity concentration to background ratio (ACR) (2.7-58). For the phantom set with contrast objects, the disks were placed centrally inside the phantoms and both phantom sets were imaged for a period of 10 min on the PEM device. In addition, scans for the 2 and 6 cm phantoms were repeated at different times (0, 90, and 150 min) post phantom construction to evaluate the impact of total activity concentration (count density) on lesion detectability. Each object from each phantom scan was then segmented and placed randomly in a corresponding blank phantom image. The resulting individual images were presented blindly to seven physician observers (two nuclear medicine and five breast imaging radiologists) and scored in a binary fashion (1-correctly identified object, 0-incorrect). The sensitivity, specificity, and accuracy of lesion detectability were calculated and plots of sensitivity versus ACR and lesion diameters for different phantom thicknesses and count density were generated. Results: The overall (mean) detection sensitivity across all variables was 0.68 (95% CI: 0.64, 0.72) with a corresponding specificity of 0.93 0.87, 0.98, and diagnostic accuracy of 0.72 0.70, 0.75. The smallest detectable object varied strongly as a function of ACR, as sensitivity ranged from 0.36 0.29, 0.44 for the smallest lesion size (3 mm) to 0.80 0.75, 0.84 for the largest (14.5 mm). Conclusions: The detectability performance of this PEM system demonstrated its ability to resolve small objects with low activity concentration ratios which may assist in the identification of early stage breast cancer. The results of this investigation can be used to correlate lesion detectability with tumor size, ACR, count rate, and breast thickness.

Original languageEnglish (US)
Pages (from-to)5176-5185
Number of pages10
JournalMedical physics
Volume38
Issue number9
DOIs
StatePublished - Jan 1 2011

Fingerprint

Mammography
Electrons
Breast
Equipment and Supplies
Nuclear Medicine
Gelatin
Breast Neoplasms
Physicians
Sensitivity and Specificity
Neoplasms

Keywords

  • PEM
  • PET
  • breast imaging
  • detectability

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Investigating the limit of detectability of a positron emission mammography device : A phantom study. / Shkumat, Nicholas A.; Springer, Adam; Walker, Christopher M.; Rohren, Eric M.; Yang, Wei Tse; Adrada, Beatriz Elena; Arribas, Elsa; Carkaci, Selin; Chuang, Hubert Hsing; Santiago, Lumarie; Mawlawi, Osama.

In: Medical physics, Vol. 38, No. 9, 01.01.2011, p. 5176-5185.

Research output: Contribution to journalArticle

@article{4fe6ef3ff2a44d8d8351d67cd7599678,
title = "Investigating the limit of detectability of a positron emission mammography device: A phantom study",
abstract = "Purpose: A new positron emission mammography (PEM) device (PEM Flex Solo II, Naviscan Inc., San Diego, CA) has recently been introduced and its performance characteristics have been documented. However, no systematic assessment of its limit of detectability has been evaluated. The aim of this work is to investigate the limit of detectability of this new PEM system using a novel, customized breast phantom. Methods: Two sets of F-18 infused gelatin breast phantoms of varying thicknesses (2, 4, 6, and 8 cm) were constructed with and without (blank) small, shell-less contrast objects (2 mm thick disks) of varying diameters (3-14.5 mm) volumes: 0.15-3.3 cc and activity concentration to background ratio (ACR) (2.7-58). For the phantom set with contrast objects, the disks were placed centrally inside the phantoms and both phantom sets were imaged for a period of 10 min on the PEM device. In addition, scans for the 2 and 6 cm phantoms were repeated at different times (0, 90, and 150 min) post phantom construction to evaluate the impact of total activity concentration (count density) on lesion detectability. Each object from each phantom scan was then segmented and placed randomly in a corresponding blank phantom image. The resulting individual images were presented blindly to seven physician observers (two nuclear medicine and five breast imaging radiologists) and scored in a binary fashion (1-correctly identified object, 0-incorrect). The sensitivity, specificity, and accuracy of lesion detectability were calculated and plots of sensitivity versus ACR and lesion diameters for different phantom thicknesses and count density were generated. Results: The overall (mean) detection sensitivity across all variables was 0.68 (95{\%} CI: 0.64, 0.72) with a corresponding specificity of 0.93 0.87, 0.98, and diagnostic accuracy of 0.72 0.70, 0.75. The smallest detectable object varied strongly as a function of ACR, as sensitivity ranged from 0.36 0.29, 0.44 for the smallest lesion size (3 mm) to 0.80 0.75, 0.84 for the largest (14.5 mm). Conclusions: The detectability performance of this PEM system demonstrated its ability to resolve small objects with low activity concentration ratios which may assist in the identification of early stage breast cancer. The results of this investigation can be used to correlate lesion detectability with tumor size, ACR, count rate, and breast thickness.",
keywords = "PEM, PET, breast imaging, detectability",
author = "Shkumat, {Nicholas A.} and Adam Springer and Walker, {Christopher M.} and Rohren, {Eric M.} and Yang, {Wei Tse} and Adrada, {Beatriz Elena} and Elsa Arribas and Selin Carkaci and Chuang, {Hubert Hsing} and Lumarie Santiago and Osama Mawlawi",
year = "2011",
month = "1",
day = "1",
doi = "10.1118/1.3627149",
language = "English (US)",
volume = "38",
pages = "5176--5185",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "9",

}

TY - JOUR

T1 - Investigating the limit of detectability of a positron emission mammography device

T2 - A phantom study

AU - Shkumat, Nicholas A.

AU - Springer, Adam

AU - Walker, Christopher M.

AU - Rohren, Eric M.

AU - Yang, Wei Tse

AU - Adrada, Beatriz Elena

AU - Arribas, Elsa

AU - Carkaci, Selin

AU - Chuang, Hubert Hsing

AU - Santiago, Lumarie

AU - Mawlawi, Osama

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Purpose: A new positron emission mammography (PEM) device (PEM Flex Solo II, Naviscan Inc., San Diego, CA) has recently been introduced and its performance characteristics have been documented. However, no systematic assessment of its limit of detectability has been evaluated. The aim of this work is to investigate the limit of detectability of this new PEM system using a novel, customized breast phantom. Methods: Two sets of F-18 infused gelatin breast phantoms of varying thicknesses (2, 4, 6, and 8 cm) were constructed with and without (blank) small, shell-less contrast objects (2 mm thick disks) of varying diameters (3-14.5 mm) volumes: 0.15-3.3 cc and activity concentration to background ratio (ACR) (2.7-58). For the phantom set with contrast objects, the disks were placed centrally inside the phantoms and both phantom sets were imaged for a period of 10 min on the PEM device. In addition, scans for the 2 and 6 cm phantoms were repeated at different times (0, 90, and 150 min) post phantom construction to evaluate the impact of total activity concentration (count density) on lesion detectability. Each object from each phantom scan was then segmented and placed randomly in a corresponding blank phantom image. The resulting individual images were presented blindly to seven physician observers (two nuclear medicine and five breast imaging radiologists) and scored in a binary fashion (1-correctly identified object, 0-incorrect). The sensitivity, specificity, and accuracy of lesion detectability were calculated and plots of sensitivity versus ACR and lesion diameters for different phantom thicknesses and count density were generated. Results: The overall (mean) detection sensitivity across all variables was 0.68 (95% CI: 0.64, 0.72) with a corresponding specificity of 0.93 0.87, 0.98, and diagnostic accuracy of 0.72 0.70, 0.75. The smallest detectable object varied strongly as a function of ACR, as sensitivity ranged from 0.36 0.29, 0.44 for the smallest lesion size (3 mm) to 0.80 0.75, 0.84 for the largest (14.5 mm). Conclusions: The detectability performance of this PEM system demonstrated its ability to resolve small objects with low activity concentration ratios which may assist in the identification of early stage breast cancer. The results of this investigation can be used to correlate lesion detectability with tumor size, ACR, count rate, and breast thickness.

AB - Purpose: A new positron emission mammography (PEM) device (PEM Flex Solo II, Naviscan Inc., San Diego, CA) has recently been introduced and its performance characteristics have been documented. However, no systematic assessment of its limit of detectability has been evaluated. The aim of this work is to investigate the limit of detectability of this new PEM system using a novel, customized breast phantom. Methods: Two sets of F-18 infused gelatin breast phantoms of varying thicknesses (2, 4, 6, and 8 cm) were constructed with and without (blank) small, shell-less contrast objects (2 mm thick disks) of varying diameters (3-14.5 mm) volumes: 0.15-3.3 cc and activity concentration to background ratio (ACR) (2.7-58). For the phantom set with contrast objects, the disks were placed centrally inside the phantoms and both phantom sets were imaged for a period of 10 min on the PEM device. In addition, scans for the 2 and 6 cm phantoms were repeated at different times (0, 90, and 150 min) post phantom construction to evaluate the impact of total activity concentration (count density) on lesion detectability. Each object from each phantom scan was then segmented and placed randomly in a corresponding blank phantom image. The resulting individual images were presented blindly to seven physician observers (two nuclear medicine and five breast imaging radiologists) and scored in a binary fashion (1-correctly identified object, 0-incorrect). The sensitivity, specificity, and accuracy of lesion detectability were calculated and plots of sensitivity versus ACR and lesion diameters for different phantom thicknesses and count density were generated. Results: The overall (mean) detection sensitivity across all variables was 0.68 (95% CI: 0.64, 0.72) with a corresponding specificity of 0.93 0.87, 0.98, and diagnostic accuracy of 0.72 0.70, 0.75. The smallest detectable object varied strongly as a function of ACR, as sensitivity ranged from 0.36 0.29, 0.44 for the smallest lesion size (3 mm) to 0.80 0.75, 0.84 for the largest (14.5 mm). Conclusions: The detectability performance of this PEM system demonstrated its ability to resolve small objects with low activity concentration ratios which may assist in the identification of early stage breast cancer. The results of this investigation can be used to correlate lesion detectability with tumor size, ACR, count rate, and breast thickness.

KW - PEM

KW - PET

KW - breast imaging

KW - detectability

UR - http://www.scopus.com/inward/record.url?scp=80052399494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052399494&partnerID=8YFLogxK

U2 - 10.1118/1.3627149

DO - 10.1118/1.3627149

M3 - Article

C2 - 21978062

AN - SCOPUS:80052399494

VL - 38

SP - 5176

EP - 5185

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 9

ER -